Avoid underdosing: full loading doses, CRRT maintenance roughly equal to CrCl 25-50 mL/min, and timing doses around IHD/SLED.
At the bedside
- 1
Give full loading doses
Always the normal loading dose regardless of RRT.
- 2
Maintenance on CRRT
Dose for CrCl ~25-50 mL/min equivalent for renally cleared drugs; higher for very high effluent rates. Prefer extended/continuous infusion for beta-lactams.
- 3
IHD / SLED timing
Give doses after dialysis or SLED sessions (or supplement after). SLED clears drugs substantially - doses resemble CRRT or higher.
- 4
Therapeutic drug monitoring
Vancomycin and aminoglycosides by levels; beta-lactam TDM where available.
- 5
Adjust when RRT stops or kidneys recover
Re-dose to native function; avoid accumulation when CRRT is interrupted for long periods.
Carbapenem on CRRT
Meropenem
- Dose
- 1 g q8h (2 g q8h for CNS/high MIC)
- Preparation
- 1 g in 50 mL NS over 3 h
- Worked example
- 70 kg on CVVHDF 25 mL/kg/h: 1 g q8h over 3 h
Antipseudomonal on CRRT
Piperacillin-tazobactam
- Dose
- 4.5 g q8h (or 3.375 g q6h)
- Worked example
- 4.5 g in 100 mL NS over 4 h every 8 h
MRSA on CRRT
Vancomycin
- Dose
- Load 20-25 mg/kg then ~15 mg/kg q24h by levels
- Worked example
- 70 kg: 1.75 g load, then 1 g q24h; trough before 3rd/4th dose
CRE on CRRT
Colistin (colistimethate sodium)
- Dose
- Load 9 million units (300 mg CBA), maintenance increased for CRRT
Typical adult antimicrobial doses on CRRT (effluent 20-25 mL/kg/h)
| Drug | CRRT dose | IHD dose (after session) |
|---|---|---|
| Meropenem | 1 g q8h (extended infusion) | 500 mg-1 g q24h |
| Piperacillin-tazobactam | 4.5 g q8h or 3.375 g q6h | 2.25 g q8-12h |
| Cefepime | 2 g q12h (1-2 g q8h if high effluent) | 1-2 g q24h |
| Ceftazidime-avibactam | 1.25 g q8h (CrCl 31-50 dose) - check effluent rate | 0.94 g q24-48h |
| Vancomycin | Load 20-25 mg/kg; ~15 mg/kg q24h by levels | Load; 500-1,000 mg after each session by levels |
| Amikacin | Load 25 mg/kg; redose by levels (q24-48h) | Load; redose after HD by levels |
| Fluconazole | 800 mg q24h (or 400 mg q12h) | 100% dose after each session |
| Levetiracetam | 500-1,000 mg q12h | 500-1,000 mg q24h + 250-500 mg after HD |
| Polymyxin B | No adjustment (load 2-2.5 mg/kg, then 1.25-1.5 mg/kg q12h) | No adjustment |
Typical values from published reviews; verify against current references and local antibiogram.
Pathophysiology
Drug removal by CRRT depends on molecular size, protein binding (only free drug is filtered), volume of distribution and effluent rate. Highly protein-bound or large-Vd drugs (e.g. ceftriaxone, linezolid, polymyxin B) are minimally affected.
Evidence
- Hoff 2020 review summarises dosing for IHD, PIRRT and CRRT for common antibiotics [Hoff 2020].
- Pharmacokinetic studies show frequent beta-lactam underexposure on CRRT with traditional renal doses.
Controversies
- Optimal beta-lactam targets (100% fT > MIC vs 4x MIC); availability of TDM.
🇮🇳 India notes
- CRE and colistin/polymyxin use are common in Indian ICUs; polymyxin B is often preferred in AKI/RRT because it needs no renal adjustment.
- Involve a clinical pharmacist where available; publish a unit-level CRRT dosing chart.
References
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

